The present invention relates to a process for preparation of substantially pure Vilazodone Hydrochloride and also relates to an isolated impurity of Vilazodone. The said process for producing Vilazodone, 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbonyl benzofuran-5-yl) piperazine represented by formula (1) or a pharmaceutically acceptable salt thereof comprises condensing the compound of formula (2) With a compound of formula (3) in an alcoholic solvent to obtain a white to yellow solid; isolating the solid obtained therefrom; slurry washing the solid obtained with water miscible solvent; dissolving the solid obtained therefrom in an amide solvent to obtain a solution; adding an aqueous solution of sodium metabisulphite and an inorganic base to the solution obtained to obtain the compound of formula (1) and optionally converting the solid obtained in step (v) to its pharmaceutically acceptable salt.
本发明涉及制备几乎纯的
维拉唑酮盐酸盐的过程,以及
维拉唑酮的一种分离杂质。所述制备
维拉唑酮的方法,即制备式(1)或其药学上可接受的盐的1-[4-(
5-氰基吲哚-3-基)丁基]-4-(2-羰基
苯并呋喃-5-基)
哌嗪,包括将式(2)的化合物与式(3)的化合物在醇溶剂中缩合,得到白色至黄色固体;从中分离得到的固体;用
水溶性溶剂混悬洗涤得到的固体;将从中得到的固体溶解于酰胺溶剂中得到溶液;向所得溶液中加入
亚硫酸钠水溶液和
无机碱,得到式(1)的化合物,可选择将步骤(v)中得到的固体转化为其药学上可接受的盐。